CompoAtlas

Gemmothérapie Bouleau

Food supplement declared in France, declaration No 2022-1-1012, decision dated 24 January 2022

Gemmothérapie Bouleau is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). 1 rule of use applies to its ingredients (limits and warnings).

Brand
not provided
Food business operator placing the product on the market
LEHMANN Gwendoline
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Compte-gouttes
Daily dose
15 Gouttes
Not recommended for (according to the manufacturer)
Allergie aux dérivés salicylés, Sous anticoagulants

Declaration 181520, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Betula pendula RothBourgeonAutre macérât0.4 ml

Other active ingredients

NamePer day
miel d’acacianot declared

Other ingredients

Alcool, eau de source

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

List recorded in 2022. Photograph the packaging to check whether it has changed. Photograph the packaging

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Other declarations with the same name

In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.

List recorded in 2022. Photograph the packaging to check whether it has changed.